ClinicalTrials.Veeva

Menu

Efficacy of Formulated Eggshell Derived Nano-hydroxyapatite Containing Toothpaste With and Without Addition of Fluoride vs. Conventional Desensitizing Fluoride Containing Toothpaste in Management of Dentin Hypersensitivity

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Not yet enrolling
Phase 1

Conditions

Fluoride
Dentin Hypersensitivity
Nano-hydroxy Apatite

Treatments

Drug: Eggshell derived Nano-hydroxyapatite (n-HAp) with a Fluoride containing toothpaste
Drug: Eggshell derived Nano-hydroxyapatite (n-HAp) without a Fluoride containing toothpaste

Study type

Interventional

Funder types

Other

Identifiers

NCT06493500
cebc-cu-2024-06-30

Details and patient eligibility

About

compare the effectiveness of Eggshell derived nano-Hydroxyapatite with and without fluoride and conventional fluoride containing tooth paste versus conventional desensitizing fluoride containing tooth paste on dentinal tubule occlusion and dentin mineral deposition.

Full description

Recently advanced nanotechnology has taken a wide leap in improving the various measures in the treatment of hypersensitivity by its nanoparticles. Nanoparticles can easily penetrate into dentin tubules, which could act as mineralizing agents that block fluid movement within the dentin tubules when combined with various agents.

Hydroxyapatite (HAp) is the major inorganic component of natural teeth and bone. Nano-sized particles of hydroxyapatite are similar to the apatite crystals of tooth enamel in morphology and crystal structure and has been studied as a biomimetic material for the reconstruction of tooth enamel suffering from mineral loss because of its unique potential for remineralization. Nano-hydroxyapatite (n-HAp) was considered a promising active ingredient used for the treatment of DH due to high biocompatibility and bioactivity. In toothpastes, HAp was included in the form of nanocrystals because they dissolve easier in this form. Crystals of n-HAp included in dental products have a dimension of 50-1000 nm, which enables them to act like fillers. These products can penetrate and block the exposed dentinal tubules which are responsible for DH

Enrollment

39 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult Patients Aged 18-60
  • Males or females.
  • Good oral hygiene
  • Absence of abnormal occlusion habits (e.g. bruxism, nail biting, tooth clenching and mouth breathing).
  • Teeth with hypersensitivity, VAS ≥5
  • Co-operative patients who show interest to participate in the study.

Exclusion criteria

  • Patients with known allergic or adverse reaction to the tested materials.
  • Systematic disease that may affect participation.
  • Xerostomic patients.
  • Patients with bad oral hygiene
  • Patients with orthodontic appliances, or bridge work that might interfere with evaluation
  • Patients who did any periodontal surgeries within the previous 6 months.
  • Patients with physical disabilities

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

39 participants in 3 patient groups

Eggshell derived Nano-hydroxyapatite (n-HAp) with Fluoride containing toothpaste
Experimental group
Description:
patients would be instructed to treat their teeth for 5 min twice a day with the provided toothpaste.
Treatment:
Drug: Eggshell derived Nano-hydroxyapatite (n-HAp) with a Fluoride containing toothpaste
Eggshell derived Nano-hydroxyapatite (n-HAp) without Fluoride containing toothpaste
Experimental group
Description:
patients would be instructed totreat their teeth for 5 min twice a day with the provided toothpaste.
Treatment:
Drug: Eggshell derived Nano-hydroxyapatite (n-HAp) without a Fluoride containing toothpaste
Commercially available Fluoride containing toothpaste (Sensodyne Rapid Relief)
Active Comparator group
Description:
patients would be instructed totreat their teeth for 5 min twice a day with the provided toothpaste.
Treatment:
Drug: Eggshell derived Nano-hydroxyapatite (n-HAp) with a Fluoride containing toothpaste

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems